Published in Ann Intern Med on September 18, 2001
Oral Vitamin K for Warfarin Associated Coagulopathy | NCT00143715
Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study. Thromb J (2008) 0.84
Care transitions in anticoagulation management for patients with atrial fibrillation: an emphasis on safety. Ochsner J (2013) 0.82
Reversal of warfarin-induced hemorrhage in the emergency department. West J Emerg Med (2011) 0.82
Reversal of oral anticoagulation. Pharmacotherapy (2013) 0.82
Effectiveness of warfarin among patients with cancer. J Gen Intern Med (2007) 0.81
Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study. Am J Kidney Dis (2014) 0.80
Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation-The EWA study. PLoS One (2017) 0.75
Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin. Am J Cardiol (2016) 0.75
Analysis of the first therapeutic-target-achieving time of warfarin therapy and associated factors in patients with pulmonary embolism. Exp Ther Med (2016) 0.75
Factors influencing warfarin response in hospitalized patients. Saudi Pharm J (2015) 0.75
Pharmacokinetic and pharmacodynamic variability of fluindione in octogenarians. Clin Pharmacol Ther (2012) 0.75
Managing excessive warfarin anticoagulation. Ann Intern Med (2001) 0.75
Reinitiating warfarin: relationships between dose and selected patient, clinical and hospital measures. Clin Med Res (2014) 0.75
Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1. Br J Pharmacol (2010) 0.75
A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med (1997) 24.87
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell (1990) 17.60
Assessing health-related quality of life in patients with sciatica. Spine (Phila Pa 1976) (1995) 7.23
Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA (1998) 6.34
The risk of acute renal failure in patients with chronic kidney disease. Kidney Int (2008) 5.87
Screening for ovarian cancer: a pilot randomised controlled trial. Lancet (1999) 5.81
Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med (1995) 5.73
The clinical information value of the glycosylated hemoglobin assay. N Engl J Med (1984) 4.79
Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med (1999) 4.54
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet (1997) 4.43
Community-based incidence of acute renal failure. Kidney Int (2007) 4.22
The Maine Lumbar Spine Study, Part III. 1-year outcomes of surgical and nonsurgical management of lumbar spinal stenosis. Spine (Phila Pa 1976) (1996) 4.11
The effect of enforcing tobacco-sales laws on adolescents' access to tobacco and smoking behavior. N Engl J Med (1997) 4.06
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med (1996) 3.86
Controlled trial prednisolone in acute polyneuropathy. Lancet (1978) 3.71
Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia (2007) 3.49
Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med (1994) 3.33
Gene discovery in the wood-forming tissues of poplar: analysis of 5, 692 expressed sequence tags. Proc Natl Acad Sci U S A (1998) 3.31
Surgical and nonsurgical management of lumbar spinal stenosis: four-year outcomes from the maine lumbar spine study. Spine (Phila Pa 1976) (2000) 3.09
Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA (1998) 3.03
Glycemic control and heart failure among adult patients with diabetes. Circulation (2001) 2.99
National patterns in the treatment of smokers by physicians. JAMA (1998) 2.94
The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch Intern Med (1991) 2.92
The Maine Lumbar Spine Study, Part II. 1-year outcomes of surgical and nonsurgical management of sciatica. Spine (Phila Pa 1976) (1996) 2.91
Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation (1990) 2.74
Case Records of the Massachusetts General Hospital--a home-court advantage? N Engl J Med (1995) 2.70
A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry (1988) 2.63
Antithrombotic therapy in atrial fibrillation. Chest (2001) 2.62
The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med (2001) 2.60
A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry (1988) 2.56
Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry (1997) 2.52
Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med (2001) 2.51
Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol (1998) 2.47
Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med (2004) 2.42
The Quebec Task Force classification for Spinal Disorders and the severity, treatment, and outcomes of sciatica and lumbar spinal stenosis. Spine (Phila Pa 1976) (1996) 2.41
Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Rheumatology (Oxford) (2004) 2.37
Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med (1996) 2.29
Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia. J Gen Intern Med (1995) 2.22
Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med (1999) 2.21
Surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: five-year outcomes from the Maine Lumbar Spine Study. Spine (Phila Pa 1976) (2001) 2.17
Nosocomial multiply resistant Klebsiella pneumoniae: epidemiology of an outbreak of apparent index case origin. Antimicrob Agents Chemother (1979) 2.13
Cardiac outcomes after regional or general anesthesia. Do we have the answer? Anesthesiology (1996) 2.12
Human immunodeficiency virus type 1 T-cell tropism is determined by events prior to provirus formation. J Virol (1990) 2.11
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation (2000) 2.09
Epidemiological study of Guillain-Barré syndrome in south east England. J Neurol Neurosurg Psychiatry (1998) 2.07
The psychometric properties of clinical rating scales used in multiple sclerosis. Brain (1999) 2.06
Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am J Med (1990) 2.06
Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study. J Clin Epidemiol (1996) 2.03
Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial infarction? JAMA (1999) 2.02
The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult Scler (1999) 2.02
Imaging in transient regional osteoporosis. Br J Rheumatol (1997) 2.01
Stroke prevention in nonvalvular atrial fibrillation. Ann Intern Med (1991) 2.01
Rationing intensive care--physician responses to a resource shortage. N Engl J Med (1983) 2.00
Long-term disability and return to work among patients who have a herniated lumbar disc: the effect of disability compensation. J Bone Joint Surg Am (2000) 1.95
Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study. Ann Intern Med (1998) 1.95
The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA (1991) 1.93
Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes (1997) 1.88
Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia. Am J Med (2000) 1.88
Relapsing polychondritis. Three cases with a clinico-pathological study and literature review. Q J Med (1972) 1.87
Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study. Am J Med (1991) 1.85
Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA (2000) 1.83
Overview of azathioprine treatment in multiple sclerosis. Lancet (1991) 1.83
Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database. Am J Med (1993) 1.83
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. Neurology (1999) 1.82
Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res (2000) 1.80
Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics. Pharmacoepidemiol Drug Saf (2002) 1.79
The use of nicotine-replacement therapy by hospitalized smokers. Am J Prev Med (1999) 1.78
National patterns of warfarin use in atrial fibrillation. Arch Intern Med (1997) 1.75
Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology (2001) 1.74
Stroke prevention in atrial fibrillation. BMJ (1997) 1.74
Patients with syncope admitted to medical intensive care units. JAMA (1982) 1.74
Congestive heart failure with preserved systolic function in a statewide sample of community hospitals. J Card Fail (2001) 1.68
Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Q J Med (1993) 1.67
Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother (1991) 1.67
Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care (2001) 1.63
Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry (2000) 1.62
Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int (2000) 1.62
The relation between expectations and outcomes in surgery for sciatica. J Gen Intern Med (1999) 1.62
Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women. Circulation (2001) 1.61
Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol (1995) 1.60
Standards of care for diabetes. Diabetes Care (1994) 1.59
Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team. Am J Med (1997) 1.59
The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol (2001) 1.58
Recent national patterns of warfarin use in atrial fibrillation. Circulation (1998) 1.57
Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med (1990) 1.57
Trigeminal sensory neuropathy. A study of 22 cases. Brain (1987) 1.56
Understanding physician adherence with a pneumonia practice guideline: effects of patient, system, and physician factors. Arch Intern Med (2000) 1.56
Factors influencing serum CA125II levels in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev (2001) 1.55
Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch Intern Med (1998) 1.55
Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med (2000) 1.55
Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med (1997) 1.54
Screening for ovarian cancer. Ann Intern Med (1994) 1.53